Prohibition Partners · Free weekly briefing
International Cannabis Weekly
The week’s global cannabis news, read through the analyst’s lens — one sentence per story, sourced.
348
7 regions30 stories5 publishers14 countries
Top story
UK medical cannabis sales surge to all-time highs
Sales of medical cannabis in the UK have been greater than expected due to ‘unusually high’ consumption volumes on a per-patient basis.
Business of CannabisGBMedical
- 01
Germany reviews 216,000 cannabis convictions
DERegulationlink no longer available
- 02
US states amass US$4.2 billion in cannabis tax revenue in 2023
USRegulationlink no longer available
Europe
7 stories- Medical cannabis sector turning a corner in Europe
The TimesEUMedical
- UK CBD industry advances as FSA issues first positive novel food safety assessments
GBHemp & CBDlink no longer available
- Synbiotic acquires German wholesaler Weeco as Clever Leaves and OCT plan delistings
DEBusiness & Investmentlink no longer available
- Czech Republic MPs agree to allow sale of HHC, kratom and low-THC cannabis products
NewsweedCZRegulation
- Luxembourg maintains strict THC limit for motorists despite political pressure
LURegulationlink no longer available
- German Cancer Research Center provides information on therapeutic cannabis-based medicines
DEMedicallink no longer available
- Stocks report
Business of CannabisEvents & Industry
United States
6 stories- DEA administrator absent from cannabis rescheduling decision did not sign order
USRegulationlink no longer available
- New York Mayor leads effort to shut down illegal cannabis sales in city neighbourhoods
USAdult-uselink no longer available
- Canopy Growth confirms Canopy USA exercises options to acquire Wana and Jetty
USBusiness & Investmentlink no longer available
- High Times puts assets up for sale to gather cash for creditors
USBusiness & Investmentlink no longer available
- Survey finds most Americans who tried cannabis or psychedelics had positive experiences
USHealth & Sciencelink no longer available
- South Dakota cannabis activists submit signatures for November ballot legalisation measure
USAdult-uselink no longer available
Canada
6 stories- Medical cannabis exports from Canada jump to CA$220 million as domestic sales fall
CABusiness & Investmentlink no longer available
- Cronos expands into UK after setting up in Germany's nascent market
- Canadabis Capital expands into European cannabis market through distribution agreement
CAEUBusiness & Investmentlink no longer available
- SNDL speeds up acquisition of majority positions in two US cannabis companies
CAUSBusiness & Investmentlink no longer available
- Village Farms reports record Q1 2024 with cannabis sales up 49% to CA$37.4 million
BenzingaCABusiness & Investment
- Ontario Cannabis Store plans to allow farmgate stores to sell cannabis products
StratCannCARegulation
LATAM & Caribbean
2 stories- Sannabis ships first cannabis essential oil from Colombia to US
COUSBusiness & Investmentlink no longer available
- Panama City mayor favours progressive approach to cannabis policy reform
PARegulationlink no longer available
Africa & Middle East
2 stories- Morocco cannabis farmers push for adult-use legalisation
MAAdult-uselink no longer available
- Medigrow launches Eastern Cape's biggest medicinal cannabis project
ZAMedicallink no longer available
APAC
1 story- Thai PM says cannabis will be re-listed as narcotic by end of 2024
THRegulationlink no longer available
Oceania
3 stories- Aurora marks first shipment of medical cannabis products to New Zealand
NZMedicallink no longer available
- Montu and Cannatrek strike new distribution deal in Australia
AUBusiness & Investmentlink no longer available
- MedReleaf and Aurora Cannabis launch dried flower products in Australia
AUBusiness & Investmentlink no longer available
Never miss an issue
International Cannabis Weekly in your inbox every week — the global developments that move the market, with the data behind them.
From the research library
Global Medical Cannabis Market Review
14 key international markets, 2025–2030. Sizing, forecasts and regulatory outlook.
From £1,265
View report